8-K
Current Report
Fulcrum Therapeutics, Inc. Filed Acc 0001193125-26-257376
Exit or restructuring costs · Other events
- Item 2.05 Costs associated with exit or disposal activities
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading fulc-20260531.htm…